000			02215ngm a2200529 a 4500
001			HST3665
003			UkLoHST
006			m c
007			cr|cna|||a||||
007			vz|czazum
008			140722s2014 enk|||||||||||s|||v|eng d
028	5	0	_a3665 _bHenry Stewart Talks
035			_a(UkLoHST)2816
040			_aUkLoHST _beng _cUkLoHST
100	1		_aCalabresi, Paolo, _u(University of Perugia, Italy) _4spk
245	1	0	_aSynaptic plasticity in striatal function _h[electronic resource] / _cPaolo Calabresi.
260			_aLondon : _bHenry Stewart Talks, _c2014.
300			_a1 online resource (1 streaming video file (37 min.) : _bcolor, sound).
490	1		_aParkinson's disease, _x2056-452X
500			_aAnimated audio-visual presentation with synchronized narration.
500			_aTitle from title frames.
505	0		_aContents: Basal ganglia circuits -- Synaptic Plasticity and Striatal Neurotransmitters -- Synaptic Plasticity and NMDA Receptors -- Dopamine and Parkinson's Disease -- Dopamine Receptors and Striatal Neurons -- Parkinson's Disease and Levodopa-induced Dyskinesia.
506			_aAccess restricted to subscribers.
538			_aMode of access: World Wide Web.
650		0	_aAntiparkinsonian agents.
650		0	_aBasal ganglia _xDiseases.
650		0	_aBasal ganglia _xPhysiology.
650		0	_aDopa _xPhysiological effect.
650		0	_aNeuroplasticity.
650		0	_aParkinson's disease _xChemotherapy.
650		0	_aParkinson's disease.
650		2	_aAntiparkinson Agents.
650		2	_aBasal Ganglia.
650		2	_aCorpus Striatum _xmetabolism.
650		2	_aCorpus Striatum _xphysiopathology.
650		2	_aDopamine _xmetabolism.
650		2	_aLevodopa _xadverse effects.
650		2	_aNeuronal Plasticity.
650		2	_aParkinson Disease _xmetabolism.
650		2	_aParkinson Disease _xphysiopathology.
650		2	_aReceptors, N-Methyl-D-Aspartate _xmetabolism.
650		2	_aSynapses _xphysiology.
650		2	_aSynaptic Transmission _xphysiology.
830		0	_aHenry Stewart talks. _pBiomedical & life sciences collection. _pParkinson's disease.
856	4	0	_uhttps://hstalks.com/bs/2816/
856	4	2	_uhttps://hstalks.com/bs/p/805/ _3Series
999			_c77047 _d77047